findmyKOL

Robert Leonardi, MD

Basic profile

Lexington Medical Center

ORCIDNone on fileNPI
RegionWest Columbia, SC · SoutheastSpecialtyInterventional CardiologyFocusCardiology
Last active 2023findmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2023Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Robert Leonardi is a Cardiology physician affiliated with Lexington Medical Center. OpenAlex indexes 24 publications with 1,043 citations (h-index 9).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
24publications

Distinct works indexed by OpenAlex.

1,043citations

Total citations across indexed works.

9h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
6companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments

Industry payments

6 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

6 companies with payments on record in CMS Open Payments (2021 onward), matched to this physician's NPI. The itemized breakdown by company, amount and year is part of the full profile. Why? →

Medicare prescribing footprint (2023)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    75%
    Beta blocker19.4%
    Metoprolol Succinate49%Carvedilol45%Metoprolol Tartrate4%Sotalol3%
    Part D<11 patients
    Statin13.4%
    Atorvastatin Calcium71%Rosuvastatin Calcium18%Pravastatin Sodium7%Simvastatin4%
    Part D<11 patients

    + 15 more classes in this area

  • Blood & clotting

    19%
    Factor Xa inhibitor12.5%
    Eliquis95%Xarelto5%
    Part D<11 patients
    P2Y12 inhibitor5.7%
    Clopidogrel68%Brilinta32%
    Part D72 patients

    + 1 more class in this area

  • Metabolism & gastrointestinal

    3.7%
    Potassium supplement2%
    Potassium Chloride71%Klor-Con M2029%
    Part D21 patients
    SGLT2 inhibitor0.9%
    Farxiga63%Jardiance38%
    Part D<11 patients

    + 1 more class in this area

Where care is delivered (Part B)32.3% facility · 67.7% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”